Edesa Biotech, Inc.
EDSA
$1.45
-$0.03-2.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.79M | 12.36M | 13.90M | 1.56M | 1.04M |
| Total Receivables | 642.90K | 286.70K | 382.40K | 350.60K | 270.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 77.80K | 112.70K | 108.20K | 157.80K | 367.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 11.51M | 12.76M | 14.39M | 2.07M | 1.68M |
|
|
|||||
| Total Current Assets | 11.51M | 12.76M | 14.39M | 2.07M | 1.68M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | 18.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.98M | 2.00M | 2.03M | 2.05M | 2.08M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 40.00K | 40.70K | 38.70K | 38.70K | 41.20K |
| Total Assets | 13.53M | 14.80M | 16.45M | 4.16M | 3.81M |
|
|
|||||
| Total Accounts Payable | 1.08M | 672.70K | 914.70K | 1.90M | 1.81M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | 19.90K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.08M | 672.70K | 914.70K | 1.90M | 1.83M |
|
|
|||||
| Total Current Liabilities | 1.08M | 672.70K | 914.70K | 1.90M | 1.83M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.08M | 672.70K | 914.70K | 1.90M | 1.83M |
|
|
|||||
| Common Stock & APIC | 69.27M | 68.68M | 68.50M | 61.74M | 60.81M |
| Retained Earnings | -65.91M | -63.65M | -61.86M | -60.23M | -58.59M |
| Treasury Stock & Other | -165.80K | -123.10K | -287.70K | -224.00K | -242.60K |
| Total Common Equity | 3.19M | 4.91M | 6.35M | 1.28M | 1.98M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 9.26M | 9.22M | 9.19M | 981.20K | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 9.26M | 9.22M | 9.19M | 981.20K | -- |
|
|
|||||
| Total Common Equity | 3.19M | 4.91M | 6.35M | 1.28M | 1.98M |
| Total Preferred Equity | 9.26M | 9.22M | 9.19M | 981.20K | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.45M | 14.13M | 15.54M | 2.26M | 1.98M |
|
|
|||||